Patients with IBD in rural areas are significantly less likely to receive advanced therapies and multidisciplinary care compared with their urban counterparts.

In a retrospective study, overlapping biologic therapy for ulcerative colitis or Crohn disease did not significantly increase risk of infections.

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

For patients with BRAF V600E-mutated metastatic CRC, overall survival significantly longer with encorafenib + cetuximab + chemotherapy.

Hormel Foods is recalling more than 256,000 pounds of its Dinty Moore Beef Stew amid reports that wood fragments were found in some cans.

Federal health officials pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing sharp criticism from experts.

An estimated 5.17% of patients with inflammatory bowel diseases also have bronchiectasis, as shown in chest CT scans of patients with IBD.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Among patients with gastroparesis, cannabis users were more likely than non-users to visit the emergency department or require hospital admission.

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Gut-directed hypnotherapy reduces overall symptom burden and abdominal pain in those with irritable bowel syndrome, according to a recent study.